Stock Detail
INSPIRE PHARMACEUTICALS INC
Drug Manufacturers Other
ISPH @ Yahoo Finance | ISPH Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $3.73 | $3.83 | $0.06 | 1.63% | 0.00 | $3.67 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $3.66 | $3.63 | 1.14M | 308.98M | 1.56M | -8.67 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 3.93 | 3.83 | 3.73 | 3.63 | 3.53 |
Stock Profile
Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovery, development, and commercialization of prescription pharmaceutical products in the ophthalmic and respiratory therapeutic areas. It has product candidates in various stages of clinical development and various programs in preclinical development. The company's clinical product candidates are based on proprietary technology relating to P2 receptors. Its products in clinical development include INS365 Ophthalmic for treating dry eye disease and corneal wound healing; INS37217 Respiratory for the treatment of cystic fibrosis; INS37217 Ophthalmic for the treatment of retinal disease; and INS50589 Antiplatelet for use in acute cardiac care. In addition, the company has rights to co-promote Elestat, for the treatment of allergic conjunctivitis; and Restasis, for the treatment of dry eye disease in the United States under collaborative agreements with Allergan, Inc. It also has collaborative partnerships with Santen Pharmaceutical Co., Ltd., and Cystic Fibrosis Foundation Therapeutics, Inc., as well as license agreements with the University of North Carolina at Chapel Hill and Wisconsin Alumni Research Foundation. The company was incorporated in 1993 and is based in Durham, North Carolina.